A second coronavirus vaccine developed in India is set to enter phase three clinical trial ‘very, very soon’
SINGAPORE — Indian drugmaker Cadila Healthcare is about to start out a section three scientific trial for a possible ...
Read more
SINGAPORE — Indian drugmaker Cadila Healthcare is about to start out a section three scientific trial for a possible ...
Read more
